Vancomycin-resistant enterococci (VRE) are a group of bacteria that have developed resistance to vancomycin, an antibiotic commonly used to treat serious infections. These bacteria, particularly ...

Disclaimer: AlphaGalileo is not responsible for the accuracy of news releases posted to AlphaGalileo by contributing ...

A recent study by a team from Chiba University has demonstrated a promising approach for fighting antibiotic resistance by identifying a compound, V-161, that inhibits a sodium-pumping enzyme critical ...

Our experience confirms and extends the findings of a previous case series on the use of daptomycin for the treatment of VRE UTIs. The previous study [12] of 5 hospitalized patients with ...

The second project proposal will specifically target Vancomycin-resistant enterococci (VRE) and as the name suggests VRE are bacteria that are resistant to the antibiotic vancomycin. VRE are ...

The major objective of this research collaboration is to develop new therapeutic drug candidates which target antimicrobial resistant pathogens. This work will utilize the Immuron technology platform, ...

Background Vancomycin-resistant enterococci are a leading cause of hospital-acquired urinary tract infection and a growing concern for the clinician. The aim of this study was to evaluate the ...

V-161 targets a crucial enzyme in VRE, offering promise in combating antibiotic-resistant infections in hospital environments A major finding of this study was the high-resolution structural ...